AstraZeneca | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-AstraZeneca PLC(4.88%),AstraZeneca UK Limited(4.88%)
Feb 12 10:14 ET
AstraZeneca | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-BlackRock, Inc.(9.1%)
Jan 24 17:26 ET
AstraZeneca | SC 13D/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-AstraZeneca Holdings B.V.(22.4%),AstraZeneca PLC(22.4%)
Nov 16, 2023 11:16 ET
AstraZeneca | SC 13D: Statement of acquisition of beneficial ownership by individuals-AstraZeneca Holdings B.V.(22.4%),AstraZeneca PLC(22.4%)
Nov 9, 2023 17:07 ET
AstraZeneca | 11-K: Annual report of employee stock purchase, savings and similar plans (and amendment thereto)
Jun 28, 2023 17:28 ET
AstraZeneca | SC 13G/A: Statement of acquisition of beneficial ownership by individuals(Amendment)-MedImmune Limited(3.4%),AstraZeneca PLC(3.4%)
Feb 10, 2023 10:25 ET
AstraZeneca | SC 13G/A: Statement of acquisition of beneficial ownership by individuals(Amendment)-AstraZeneca AB(4.8%),AstraZeneca PLC(4.8%)
Feb 10, 2023 10:22 ET
AstraZeneca | SC 13G/A: Statement of acquisition of beneficial ownership by individuals(Amendment)-BlackRock, Inc.(9.6%)
Jan 24, 2023 13:56 ET
AstraZeneca | SC 13G: Statement of acquisition of beneficial ownership by individuals-BlackRock, Inc.(10.2%)
Jul 8, 2022 16:56 ET
AstraZeneca | 11-K: Annual report of employee stock purchase, savings and similar plans (and amendment thereto)
Jun 28, 2022 21:23 ET
AstraZeneca | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-BlackRock, Inc.(9.0%)
Feb 7, 2022 16:33 ET
AstraZeneca | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-Wellington Management Group LLP(4.23%),Wellington Group Holdings LLP(4.23%), etc.
Feb 4, 2022 09:06 ET
AstraZeneca | SC 13G: Schedule filed to report acquisition of beneficial ownership of more than 5% of a class of equity securities by passive investors and certain institutions
Jul 27, 2021 13:20 ET
AstraZeneca | 11-K: Annual report of employee stock purchase, savings and similar plans (and amendment thereto)
Jun 29, 2021 10:56 ET
AstraZeneca | SC 13G: Schedule filed to report acquisition of beneficial ownership of more than 5% of a class of equity securities by passive investors and certain institutions
Apr 7, 2021 17:37 ET
AstraZeneca | 4: Statement of changes in beneficial ownership of securities
Mar 16, 2021 08:52 ET
AstraZeneca | SC 13G: Schedule filed to report acquisition of beneficial ownership of more than 5% of a class of equity securities by passive investors and certain institutions
Feb 10, 2021 16:01 ET
AstraZeneca | SC 13G/A: Schedule filed to report acquisition of beneficial ownership of more than 5% of a class of equity securities by passive investors and certain institutions (Amendment)
Feb 10, 2021 16:01 ET
AstraZeneca | SC 13G/A: Schedule filed to report acquisition of beneficial ownership of more than 5% of a class of equity securities by passive investors and certain institutions (Amendment)
Feb 3, 2021 13:13 ET
AstraZeneca | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-BlackRock, Inc.(8.8%)
Jan 28, 2021 18:11 ET
No Data
No Data